Business
Eli Lilly Expands GLP-1 Pill Production
Eli Lilly is ramping up production of its new GLP-1 pill, Foundayo, as one-third of patients are already taking the drug. The company aims to catch up with Novo Nordisk in this growing market.
Coverage timeline — 1 article
CNBC
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
2026-09-21 17:06 UTC